Amgen CEO Bob Bradway hailed progress by the biopharmaceutical industry against COVID-19

Amgen to Showcase New Data From Its Oncology Pipeline in Lung Cancer at the World Conference on Lung Cancer

Learn more about new data that will be presented on lung cancer at the World Conference on Lung Cancer 2020—and hear from Greg Friberg, vice president and therapeutic area head for Global Development Oncology.

This year’s conference is a virtual, worldwide event, but pre-registration is required.

View the WCLC Scientific Program, including the full abstract list.

Throughout WCLC, follow along on our social handles on Twitter and LinkedIn, and learn more about how Amgen Oncology is advancing its pioneering science with the relentless pursuit of innovative modalities and unique pathways for cancer patients and their families at

Share This Story